Phase III trial of cisplatin plus gemcitabine with either placebo or bevacizumab as first-line therapy for nonsquamous non-small-cell lung cancer: AVAil - Reck, M; von Pawel, J; Zatloukal, P (J Clin Oncol, 2009)